ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gerald D. Buckberg
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castellá, M.
Right arrow Articles by Tan, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castellá, M.
Right arrow Articles by Tan, Z.
Related Collections
Right arrow Myocardial protection

Ann Thorac Surg 2003;75:1238-1245
© 2003 The Society of Thoracic Surgeons


Original article: cardiovascular

Blood cardioplegic protection in profoundly damaged hearts: role of Na+-H+ exchange inhibition during pretreatment or during controlled reperfusion supplementation

Manuel Castellá, MDa, Gerald D. Buckberg, MDa*, Zhongtuo Tan, PhDa

a Department of Surgery, Division of Cardiothoracic Surgery, University of California, Los Angeles, School of Medicine, Los Angeles, California, USA

Accepted for publication September 19, 2002.

* Address reprint requests to Dr Buckberg, Division of Cardiothoracic Surgery, 62-258 Center For the Health Sciences, Los Angeles, CA 90095-1701, USA.
e-mail: gbuckberg{at}mednet.ucla.edu

BACKGROUND: Inhibition of the Na+/H+ exchanger before ischemia protects against ischemia-reperfusion injury, but use as pretreatment before blood cardioplegic protection or as a supplement to controlled blood cardioplegic reperfusion was not previously tested in jeopardized hearts.

METHODS: Control studies tested the safety of glutamate-aspartate–enriched blood cardioplegic solution in 4 Yorkshire-Duroc pigs undergoing 30 minutes of aortic clamping without prior unprotected ischemia. Twenty-four pigs underwent 30 minutes of unprotected normothermic global ischemia to create a jeopardized heart. Six of these hearts received normal blood reperfusion, and the other 18 jeopardized hearts underwent 30 more minutes of aortic clamping with cardioplegic protection. In 12 of these, the Na+/H+ exchanger inhibitor cariporide was used as intravenous pretreatment (n = 6) or added to the cardioplegic reperfusate (n = 6).

RESULTS: Complete functional, biochemical, and endothelial recovery occurred after 30 minutes of blood cardioplegic arrest without preceding unprotected ischemia. Thirty minutes of normothermic ischemia and normal blood reperfusion produced 33% mortality and severe left ventricular dysfunction in survivors (preload recruitable stroke work, 23% ± 6% of baseline levels), with raised creatine kinase MB, conjugated dienes, endothelin-1, myeloperoxidase activity, and extensive myocardial edema. Blood cardioplegia was functionally protective, despite adding 30 more minutes of ischemia; there was no mortality, and left ventricular function improved (preload recruitable stroke work, 58% ± 21%, p < 0.05 versus normal blood reperfusion), but adverse biochemical and endothelial variables did not change. In contrast, Na+/H+ exchanger inhibition as either pretreatment or added during cardioplegic reperfusion improved myocardial recovery (preload recruitable stroke work, 88% ± 9% and 80% ± 7%, respectively, p < 0.05 versus without cariporide) and comparably restored injury variables.

CONCLUSIONS: Na+/H+ exchanger blockage as either pretreatment or during blood cardioplegic reperfusion comparably delays functional, biochemical, and endothelial injury in jeopardized hearts.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Castella, G. D. Buckberg, and S. Saleh
Diastolic dysfunction in stunned myocardium: a state of abnormal excitation-contraction coupling that is limited by Na+-H+ exchange inhibition
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S107 - S114.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. D. Buckberg
Stroke and extra-cardiac perfusion: new vantage points in brain protection
Eur. J. Cardiothorac. Surg., December 1, 2004; 26(Suppl_1): S62 - S67.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Castella, G. D. Buckberg, S. Saleh, Z. Tan, and L. J. Ignarro
A new role for cardioplegic buffering: should acidosis or calcium accumulation be counteracted to salvage jeopardized hearts?
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1442 - 1448.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. S. Galvez, J. A. Ulloa, M. Chiong, A. Criollo, V. Eisner, L. F. Barros, and S. Lavandero
Aldose Reductase Induced by Hyperosmotic Stress Mediates Cardiomyocyte Apoptosis: DIFFERENTIAL EFFECTS OF SORBITOL AND MANNITOL
J. Biol. Chem., October 3, 2003; 278(40): 38484 - 38494.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.